Financials
Financial year 2025
STUDIECENTRUM Thoraco Vasculaire Heelkunde from Genk, company number BE0840205783, closed financial year 2025 with a result of € 129,258 after tax. For that financial year STUDIECENTRUM Thoraco Vasculaire Heelkunde recorded a gross margin of € 134,855 and equity of € 10,193. Compared with financial year 2024, the result moved from € 187,927 to € 129,258. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 10,193
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 129,258
▼ 31% vs 2024
Profit after tax over the fiscal year.
€ 118,603
▼ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 128,000 paid out
99 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,424
▼ 88% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,561
▲ 87% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 375,389 | € 204,786 | € 191,166 | € 134,855 | ▼ 29% |
| Profit after taxes | € 373,816 | € 204,089 | € 187,927 | € 129,258 | ▼ 31% |
| Equity | € 8,877 | € 8,509 | € 8,935 | € 10,193 | ▲ 14% |
| Total debts | € 412,385 | € 211,905 | € 320,256 | € 134,985 | ▼ 58% |
| Cash | € 266,281 | € 182,107 | € 244,536 | € 118,603 | ▼ 51% |
| Retained profit | € 2,277 | € 1,909 | € 2,335 | € 3,593 | ▲ 54% |
| Dividend | € 373,900 | € 204,457 | € 187,500 | € 128,000 | ▼ 32% |
| Balance sheet total | € 421,262 | € 220,413 | € 329,192 | € 145,178 | ▼ 56% |
Key figures of STUDIECENTRUM Thoraco Vasculaire Heelkunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to STUDIECENTRUM Thoraco Vasculaire Heelkunde?
What happened at STUDIECENTRUM Thoraco Vasculaire Heelkunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 129,258 (▼ 31% vs 2024). Source: NBB ↗
- New establishment in Genk. KBO
- Dokterspraktijk Lauwers en Van Hoestenberghe BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 373,816 profit in 2022 to € 129,258 profit in 2025.
Paid € 4,846 in corporate taxes since 2022.
Best year ever: 2022, with € 373,816 profit.
Paid out € 893,857 in dividends to the owners in total.
A new publication or filing at STUDIECENTRUM Thoraco Vasculaire Heelkunde? We notify you, reason included.
Follow STUDIECENTRUM Thoraco Vasculaire HeelkundeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DOKTERSPRAKTIJK LAUWERS EN VAN HOESTENBERGHE, DR. W. LANSINK, Dokter Sigi Nauwelaers, Dr. Schroe Herman comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
STUDIECENTRUM Thoraco Vasculaire HeelkundeBehind STUDIECENTRUM Thoraco Vasculaire Heelkunde are Dokterspraktijk Lauwers en Van Hoestenberghe BV, Geheel BV, Dokter W. Lansink BV and Dokter Sigi Nauwelaers BV. The shares are held by DOKTERSPRAKTIJK LAUWERS EN VAN HOESTENBERGHE (27.5%), DR. W. LANSINK (25%), Dokter Sigi Nauwelaers (17.5%) and Dr. Schroe Herman (1%).
Directors
According to the 2025 annual accounts
Dokterspraktijk Lauwers en Van Hoestenberghe BV
Director · represented by Lauwers Geert
since 2011
Director · represented by Decaluwé Herbert
Director · represented by Wouter Lansink
Director · represented by Sigi Nauwelaers
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Wildekastanjelaan 13
3600 Genk
Schiepse Bos 6
3600 Genk
Active since 12 October 2011
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0840.205.783
- VAT number
- BE 0840.205.783
- Registered office
- Wildekastanjelaan 13, 3600 Genk
- Names & denominations
- STUDIECENTRUM Thoraco Vasculaire Heelkunde · TVH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 October 2011
- Peppol
- Active · Active since 24 Mar 2026
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten